https://www.bloomberg.com/news/articles/2021-06-14/emergent-pledges-fda-improvements-at-troubled-vaccine-plant
Emergent BioSolutions Inc. is promising the Food and Drug Administration a series of fixes in response to an inspection that led to a halt in production at a company facility that had been making Johnson & Johnson’s Covid-19 vaccine.

Emergent Pledges FDA Improvements at Troubled Vaccine Plant
More from BusinessMore posts in Business »
- Gold ends week higher despite Powell’s pushback, trade uncertainty lingers
- EUR/USD climbs as US Dollar weakens on trade tensions
- Forex Today: Markets stabilize as trading volume thins out on Easter Friday
- US Dollar Index hovers near 99.50 as trading activity remains muted due to Good Friday
- Follow the leaders
- Starbucks gets a new dress code, Tesla falls behind, and Trump wants Powell out: Business news roundup
- Tumbling stocks, recession fears, and a retail sales surge: Markets news roundup
- Meta’s antitrust trial, Nvidia’s stateside manufacturing, and 7 AI breakthroughs: Tech news roundup
- Meta’s antitrust trial heats up: Here’s what we’ve learned so far
- Eli Lilly promises to make new weight loss pill in the U.S.
More from UncategorizedMore posts in Uncategorized »
- Gold ends week higher despite Powell’s pushback, trade uncertainty lingers
- EUR/USD climbs as US Dollar weakens on trade tensions
- Forex Today: Markets stabilize as trading volume thins out on Easter Friday
- US Dollar Index hovers near 99.50 as trading activity remains muted due to Good Friday
- Follow the leaders
- Starbucks gets a new dress code, Tesla falls behind, and Trump wants Powell out: Business news roundup
- Tumbling stocks, recession fears, and a retail sales surge: Markets news roundup
- Meta’s antitrust trial, Nvidia’s stateside manufacturing, and 7 AI breakthroughs: Tech news roundup
- Meta’s antitrust trial heats up: Here’s what we’ve learned so far
- Eli Lilly promises to make new weight loss pill in the U.S.